CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 58.18 CNY -2.14% Market Closed
Market Cap: 9.4B CNY

Operating Margin
CanSino Biologics Inc

-29.3%
Current
-193%
Average
6.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-29.3%
=
Operating Profit
-254.4m
/
Revenue
869.2m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CN
CanSino Biologics Inc
SSE:688185
9.4B CNY
-29%
US
Eli Lilly and Co
NYSE:LLY
682.1B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
367.4B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK
48%
CH
Roche Holding AG
SIX:ROG
206.2B CHF
33%
CH
Novartis AG
SIX:NOVN
181.8B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
160.9B GBP
24%
US
Merck & Co Inc
NYSE:MRK
196.4B USD
34%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
11%
FR
Sanofi SA
PAR:SAN
116.8B EUR
22%

CanSino Biologics Inc
Glance View

Market Cap
9.4B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
52.52 CNY
Overvaluation 10%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-29.3%
=
Operating Profit
-254.4m
/
Revenue
869.2m
What is the Operating Margin of CanSino Biologics Inc?

Based on CanSino Biologics Inc's most recent financial statements, the company has Operating Margin of -29.3%.

Back to Top